Chronic rhinosinusitis (CRS) is a common health care problem, yet many aspects of this diagnosis remain poorly understood. Its etiology is often debated and remains a significant area of research.

which assessed the efficacy and safety of depemokimab versus placebo in adults with chronic rhinosinusitis with nasal polyps (CRSwNP). Both trials met their co-primary endpoints of a change from ...

The review article (1) discusses complicated sinusitis in an excellent way. Precise terminology is important since clinical jargon often does not differentiate between (orbital) abscess and ...

GSK said its depemokimab respiratory drug met the main objectives in two late-stage clinical trials, showing efficacy for the treatment of chronic rhinosinusitis with nasal polyps. The U.K ...

Clinical research interests of the faculty include outcomes of complicated frontal sinus surgery, novel surgical methods to improve Cystic Fibrosis-related chronic sinusitis, and advanced techniques ...

About LYR-210 LYR-210 is an investigational product candidate for the treatment of chronic rhinosinusitis (CRS) in patients who have failed current therapies and require further intervention.

No writing assistance was utilized in the production of this manuscript. Chronic rhinosinusitis is one of the most common clinical syndromes in the USA. The etiology of chronic rhinosinusitis is ...